Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies by Alonso Daniel F, Gómez Roberto, Ramos Thelvia, Castillo Dagnelia, Díaz Alina, González Carlos A, Valenzuela Carmen, Baladrón Idania, Santana Agueda, Solares Ana M, Herrera Luis, Sigman Hugo, Perea Silvio E, Acevedo Boris E, López-Saura Pedro

Get full text